TMRW Life Sciences, Inc., creator of the only FDA-cleared automated specimen management and storage platform for frozen human sperm, eggs and embryos, has officially announced the opening of a new state-of-the-art cryostorage facility in Colorado. According to certain reports, the stated facility is going to be TMRW’s second location alongside the one in New York City, both focused on growing a network of offsite cryostorage offerings that use the world’s first automated platforms for safe management and storage of frozen specimens. To understand the significance behind such a development, though, we must acknowledge how more than 5 million frozen eggs and embryos are, at the moment, stored at fertility clinics around the United States in legacy biorepositories, all of it done using antiquated systems prone to human error. This is a big reason why fertility clinics are now running out of space and are in dire need of digital specimen management and offsite storage solutions that can effectively reduce operational inefficiencies, as well as the risks of mix-ups, errors, loss, and lawsuits. Fortunately enough, TMRW’s latest facility fills up that need through a fully integrated digital platform which is capable of reducing paperwork, improving operational efficiencies, providing real time specimen visibility, and supporting the clinic-patient relationship. Another detail worth a mention here is how TMRW’s systems on location use some of the most important improvements in cryostorage of the 21st century, including RFID-enabled tracking and tracing, EMR integration, digital chain of custody and audit trails, and coordination with lab witnessing products.
“TMRW’s embryology teams, including those onsite at our biorepositories and onsite in clinics digitizing legacy inventories, have 180+ years of combined embryology, andrology and/or lab experience,” said Lori Batta, Chief Operating Officer at TMRW. “They work in lock-step with our fertility clinic partners as an extension of their labs managing short- and long-term storage needs with a logistics operation built to meet the dynamic nature of IVF cycles.”
More on the same would reveal that TMRW’s Boulder facility arrives on the scene with an around-the-clock monitoring mechanism, provided by TMRW’s Overwatch system. This mechanism alone can conduct tens of thousands of daily checks with remote monitoring. Such a setup, on its part, can alert TMRW’s dedicated team well before any problems arises.
Markedly enough, TMRW’s would pick Boulder as the location for its latest facility due to its low risk of earthquakes, fires, tornadoes, hurricanes, and natural disasters. Not just that, the city is also an easy transportation hub in a state with strong legislative and judicial support for reproductive rights.
“At Pinnacle Fertility, we prioritize the safety and success of our patients’ fertility journeys, and TMRW’s advanced technology, operational capabilities, and dedication to reducing potential points of failure provide an unprecedented level of security and reliability for our patients,” said Beth Zoneraich, CEO of Pinnacle Fertility.
Founded in 2018, TMRW Life Sciences has risen up by being the world’s first and only automated platform for safe management and storage of frozen sperm, eggs and embryos, pioneering the concept of digitally identifying, tracking, managing, and monitoring frozen specimens. To understand the company’s excellence in what it does, we can also acknowledge how it is able to reduce potential points of failure by 94% compared to manual systems. In case that wasn’t enough, then aiding the TMRW’s case even further is a fact that it has been named Fast Company’s #1 Most Innovative Biotech company for the year 2022.
“With more than 250,000 specimens under management and growth expected to continue doubling every year, TMRW’s expansion into Colorado and beyond is fueled by high demand from patients and clinics alike,” said Louis Villaba, Chief Executive Officer at TMRW.
